ArticleBlood2024

CD19 occupancy with tafasitamab increases therapeutic index of CART19 cell therapy and diminishes severity of CRS.

R Leo Sakemura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.